I have an issue with this company now. If they have good assay results, then why not release instead of raising capital with selling shares up to 1 billion following the r/s? If they have bad assay results, then that would be completely misleading to shareholders to keep that information from us and continue down this road with investors. If they never did any assay results, then why not? gg
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.